Clinical Trials
2 trialsNCT05338723 2024-02-28
Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
Tanta University
Phase 3 Completed
NCT01299038 2020-02-05
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed